Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8883206 Pharmaceutical composition and administrations thereof

Patent 8883206 was granted and assigned to Vertex Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Vertex Pharmaceuticals

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Dragutin Knezic0

Andrew G. Kuzmission0

Chong-Hui Gu0

Eleni Dokou0

HongRen Wang0

John P. Caesar, Jr.0

Laura Das0

Majed Fawaz0

...

Date of Patent

November 11, 2014

Patent Application Number

14286856

Date Filed

May 23, 2014

Patent Citations Received

US Patent 11951212 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

0

US Patent 11986554 Orally disintegrating compositions

0

US Patent 12065432 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

0

US Patent 12024491 Processes for making modulators of cystic fibrosis transmembrane conductance regulator

0

US Patent 11708331 Processes for making modulators of cystic fibrosis transmembrane conductance regulator

0

US Patent 11752106 Pharmaceutical composition and administrations thereof

Patent Primary Examiner

Jeffrey T. Palenik

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8883206 Pharmaceutical composition and administrations thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool